Broker’s call: Gland Pharma (Buy)

Target: ₹1,970 CMP: ₹1,832.45 Gland Pharma delivered better-than-expected operational performance for the quarter. Despite increased EBITDA loss at Cenexi y-o-y/q-o-q and a lower share of the milestone income, the overall EBITDA margin was better-than-expected at 21.1 per cent, led by better segmental mix and controlled operational cost for the quarter. We cut our earnings estimate…

Read More

Closing bell: Strong performance in metals and banking drives Indian stock market recovery

Indian equity benchmarks staged a strong recovery on Tuesday, erasing previous session’s losses, driven by robust performance in metal and banking stocks amid positive cues from Asian markets and expectations of stimulus measures from China. The BSE Sensex closed at 79,476.63, gaining 694.39 points or 0.88 per cent, while the NSE Nifty 50 advanced…

Read More